Edwards Lifesciences Corp. Profit Advances 25% In Q3

(RTTNews) - Edwards Lifesciences Corp. (EW) revealed earnings for its third quarter that gained ground compared to the same period last year.

The company said its bottom line came in at $148.2 million, or $0.68 per share. This was higher than $118.7 million, or $0.54 per share, in last year's third quarter.

Analysts had expected the company to earn $0.68 per share, according figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company said revenue for the quarter rose 20.1% to $739.4 million. This was up from $615.5 million last year.

Edwards Lifesciences Corp. earnings at a glance:

-Earnings (Q3): $148.2 Mln. vs. $118.7 Mln. last year. -Earnings Growth (Y-o-Y): 24.9% -EPS (Q3): $0.68 vs. $0.54 last year. -EPS Growth (Y-o-Y): 25.9% -Analysts Estimate: $0.68 -Revenue (Q3): $739.4 Mln vs. $615.5 Mln last year. -Revenue Change (Y-o-Y): 20.1%

-Guidance: Next quarter EPS guidance: $0.67 - $0.77 Next quarter revenue guidance: $750 - $790 Mln Full year EPS guidance: $0.67 - $0.77 Full year revenue guidance: $2.7 - $3.0 Bln